Real-world data on the use of secukinumab as treatment for moderate-to-severe psoriasis in Chinese patients

被引：0
|
作者：
He Huang
Ming-Long Cai
Xiao-Jie Hong
Li-Jun Zheng
Zhu-Lin Hu
Tao Yuan
Wei-Ran Li
Yu-Jun Sheng
Xue-Jun Zhang
机构：
[1] the First Affiliated Hospital of Anhui Medical University,Department of Dermatology
[2] Anhui Medical University,Institute of Dermatology
[3] Anhui Medical University,Key Laboratory of Dermatology
[4] Ministry of Education,State Key Laboratory Incubation Base of Dermatology
[5] Anhui Medical University,undefined
[6] Key Laboratory of Major Autoimmune Diseases,undefined
来源：
European Journal of Dermatology | 2020年 / 30卷
关键词：
psoriasis; secukinumab; efficacy; safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：554 / 560
页数：6
相关论文
共 50 条
  • [1] Real-world data on the use of secukinumab as treatment for moderate-to-severe psoriasis in Chinese patients
    Huang, He
    Cai, Ming-Long
    Hong, Xiao-Jie
    Zheng, Li-Jun
    Hu, Zhu-Lin
    Yuan, Tao
    Li, Wei-Ran
    Sheng, Yu-Jun
    Zhang, Xue-Jun
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (05) : 554 - 560
  • [2] Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real-world practice
    Zhou, Jian
    Yuan, Yuan
    Liu, Yanhua
    Chu, Mengyang
    Liu, Huan
    Liu, Qian
    Wang, Rui
    Shao, Shuai
    Wang, Gang
    Yu, Chen
    [J]. EXPERIMENTAL DERMATOLOGY, 2024, 33 (01)
  • [3] Treatment outcomes of secukinumab in adult patients with moderate-to-severe plaque psoriasis in China: A real-world multicenter retrospective study
    Ding, Yangfeng
    Li, Wei
    Guan, Xin
    Liu, Na
    Zhou, Ying
    Li, Gaojie
    Wang, Xiaohua
    Wang, Zhidong
    Xiao, Xiao
    Yang, Bin
    Lv, Chengzhi
    Zhang, Chunlei
    Shi, Yuling
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (10): : 1803 - 1814
  • [4] Real-world data for evaluating effectiveness and safety of secukinumab in the treatment of scalp and palmoplantar psoriasis in adults with moderate-to-severe skin disease
    Rompoti, Natalia
    Katsimbri, Pelagia
    Kokkalis, Georgios
    Boumpas, Dimitrios
    Ikonomidis, Ignatios
    Theodoropoulos, Konstantinos
    Rigopoulos, Dimitrios
    Papadavid, Evangelia
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB264 - AB264
  • [5] Comparison of the disease survival of biologics for the treatment of moderate-to-severe psoriasis: real-world data
    Oh, S-M
    Kang, K-W
    Kang, D-H
    Kwon, S-H
    Lew, B-L
    Shin, M. K.
    Jeong, K-H
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S343 - S343
  • [6] Real-world data on the efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis
    Papadavid, E.
    Rompoti, N.
    Theodoropoulos, K.
    Kokkalis, G.
    Rigopoulos, D.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (07) : 1173 - 1179
  • [7] Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting
    Ogut, Neslihan Demirel
    Yildirim, Sema Koc
    Erbagci, Ece
    Hapa, Fatma Asli
    [J]. JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (11) : 6215 - 6224
  • [8] Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian Centers
    Vender, Ronald B.
    Lynde, Charles W.
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2022, 26 (03) : 267 - 273
  • [9] Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: real-world data from a retrospective multicenter study
    Topal, Ilteris Oguz
    Baysak, Sevim
    Altunay, Ilknur Kivanc
    Polat, Asude Kara
    Arikan, Eylem Emel
    Ozkur, Ezgi
    Aytekin, Sema
    Dogan, Bilal
    Akbulut, Tugba Ozkok
    Demir, Filiz Topaloglu
    Karadag, Ayse Serap
    [J]. ANAIS BRASILEIROS DE DERMATOLOGIA, 2022, 97 (05) : 566 - 574
  • [10] Real world data from the use of secukinumab in the treatment of moderate-to-severe psoriasis, including scalp and palmoplantar psoriasis: A 104-week clinical study
    Rompoti, Natalia
    Katsimbri, Pelagia
    Kokkalis, Georgios
    Boumpas, Dimitrios
    Ikonomidis, Ignatios
    Theodoropoulos, Konstantinos
    Rigopoulos, Dimitris
    Papadavid, Evangelia
    [J]. DERMATOLOGIC THERAPY, 2019, 32 (05)
12345